Remicade (infliximab) - J&J
lirentelimab (AK002) - Allakos
Cinqair (reslizumab) - Merck (MSD), UCB, Teva
montelukast - Generic mfg.
Xolair (omalizumab) - Roche, Novartis
Nucala (mepolizumab) - GSK
Entyvio (vedolizumab) - Takeda
Eohilia (budesonide oral) - Takeda
fluticasone - Generic mfg.
Jorveza (budesonide orodispersible tablets) - Dr Falk
Fasenra (benralizumab) - AstraZeneca
Dupixent (dupilumab) - Sanofi, Regeneron
azathioprine - Generic mfg.
http://www.ncbi.nlm.nih.gov/pubmed/39474328
 
Alain M Schoepfer; Ekaterina Safroneeva
 
Oct 30, 2024
 
Prev Next